Feature | Cardiovascular Business | January 05, 2024 | By Melinda Taschetta-Millane

2023 in Review: A Look at the Year's Top 10 Topics

The Diagnostic and Interventional Cardiology team looks back on the Top 10 topics of 2023

Related Content

News | FDA

April 25, 2024 — Provisio Medical announced FDA 510(k) clearance of the Provisio SLT IVUS System. Sonic Lumen Tomography ...

Home April 25, 2024
Home
News | FDA

April 24, 2024 — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food ...

Home April 24, 2024
Home
News | FDA

April 22, 2024 — At the annual American College of Cardiology conference (ACC.24) in Atlanta last week, RCE Technologies ...

Home April 22, 2024
Home
News | FDA

April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...

Home April 18, 2024
Home
News | FDA

April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...

Home April 15, 2024
Home
News | FDA

April 12, 2024 — Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular ...

Home April 12, 2024
Home
News | FDA

April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational ...

Home April 02, 2024
Home
News | FDA

April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...

Home April 02, 2024
Home
News | FDA

April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new ...

Home April 01, 2024
Home
News | FDA

March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug ...

Home March 28, 2024
Home
Subscribe Now